Modified Brain Injury Guidelines for preinjury anticoagulation in traumatic brain injury: An opportunity to reduce

Shea P Gallagher1, Benedict A Capacio, Alexandra S Rooney

  • 1From the Division of Trauma and Acute Care Surgery, Department of Surgery (S.P.G., B.A.C., A.S.R., R.Y.C., C.B.S., A.K., M.J.S., V.B., M.J.M.), Scripps Mercy Hospital, San Diego, California; Division of Trauma and Acute Care Surgery, Department of Surgery (S.P.G., M.J.M.), Los Angeles General Medical Center, Los Angeles, California; and Division of Trauma and Acute Care Surgery, Department of Surgery (K.B.S., W.L.B.), Scripps Memorial Hospital La Jolla, La Jolla, California.

Insights

Modified Brain Injury Guidelines (BIG) may safely reduce healthcare costs for patients on anticoagulation (AC) with traumatic brain injury (TBI). Lower-risk TBI patients on AC did not require neurosurgical intervention, suggesting potential resource savings.

Area of Science:

  • Neurosurgery
  • Traumatology
  • Geriatric Medicine

Background:

  • The Brain Injury Guidelines (BIG) stratify traumatic brain injury (TBI) severity to guide management and reduce healthcare burden.
  • Current BIG protocols mandate that all patients on anticoagulation (AC) are classified into the highest severity tertile (BIG 3).
  • This classification may lead to over-utilization of healthcare resources for TBI patients on AC.

Purpose of the Study:

  • To analyze TBI patients on AC using a modified BIG model.
  • To determine if a modified BIG approach can safely reduce healthcare resource utilization in this population.
  • To assess the safety and efficacy of stratifying TBI patients on AC into lower risk tertiles.

Main Methods:

  • Retrospective analysis of 221 patients aged 55 years or older on AC with traumatic intracranial hemorrhage (ICH) from two centers.
  • Patients were stratified into modified BIG 1 to 3 risk groups, excluding AC as a primary criterion.
  • Outcomes analyzed included intracranial hemorrhage progression, neurosurgical intervention (NSI), mortality, and discharge status.

Main Results:

  • 23%, 29%, and 48% of patients were classified as BIG 1, BIG 2, and BIG 3, respectively.
  • BIG 3 patients had higher rates of AC reversal agents, ICH progression, NSI (16%), and mortality (26%) compared to BIG 1 and 2.
  • No patients in BIG 1 or 2 required NSI, and mortality was significantly lower (15x odds for BIG 3 vs. BIG 1).

Conclusions:

  • Higher ICH progression rates in AC patients did not translate to increased NSI or mortality in lower modified BIG tertiles.
  • Applying modified BIG criteria could potentially reduce neurosurgical consultations by up to 52%.
  • Modified BIG criteria offer a safe opportunity for healthcare resource and cost savings in the TBI population on AC.
Abstract